Location: Lisbon Congress Center, Lisbon, Portugal
Dates: November 18-22, 2019
Booth: #349
RenMab™ Mouse: a leading platform for fully human antibody generation
Speaker: Chaoshe Guo, Ph.D., M.D., Vice President & Global Head of Business Development of Biocytogen
Time: November 20th, 10:05 – 10:35
Session: Advancing Bispecifics and Combination Therapy to the Clinic
Presentation Abstract:
Biocytogen has recently developed RenMab™ Mouse, a fully human antibody mouse with its entire variable regions replaced by human Ig heavy chain and light chain. The RenMab™ model has also demonstrated a similar immune response to the wild type strain as it carries the full human antibody repertoire. Combined with existing inventory of single, double or triple target humanized mouse models, Biocytogen is poised to provide an one-stop solution from target validation to IND application.
To learn more about the congress agenda, please go to https://www.pegsummiteurope.com/advancing-bispecifics
